Bruker Return on Investment 2012-2026 | BRKR
Current and historical return on investment (ROI) values for Bruker (BRKR) over the last 10 years.
| Bruker ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2026-03-31 | $0.05B | $4.27B | 1.08% |
| 2025-12-31 | $0.07B | $4.22B | 1.61% |
| 2025-09-30 | $0.06B | $4.10B | 1.56% |
| 2025-06-30 | $0.18B | $4.01B | 4.58% |
| 2025-03-31 | $0.22B | $3.95B | 5.57% |
| 2024-12-31 | $0.25B | $3.67B | 6.89% |
| 2024-09-30 | $0.29B | $3.34B | 8.52% |
| 2024-06-30 | $0.34B | $2.90B | 11.75% |
| 2024-03-31 | $0.38B | $2.51B | 15.09% |
| 2023-12-31 | $0.44B | $2.39B | 18.28% |
| 2023-09-30 | $0.46B | $2.33B | 19.89% |
| 2023-06-30 | $0.47B | $2.27B | 20.72% |
| 2023-03-31 | $0.46B | $2.22B | 20.69% |
| 2022-12-31 | $0.43B | $2.20B | 19.68% |
| 2022-09-30 | $0.43B | $2.20B | 19.45% |
| 2022-06-30 | $0.41B | $2.13B | 19.24% |
| 2022-03-31 | $0.42B | $2.02B | 20.82% |
| 2021-12-31 | $0.41B | $1.89B | 21.89% |
| 2021-09-30 | $0.40B | $1.77B | 22.72% |
| 2021-06-30 | $0.37B | $1.76B | 20.96% |
| 2021-03-31 | $0.32B | $1.78B | 17.99% |
| 2020-12-31 | $0.25B | $1.82B | 13.63% |
| 2020-09-30 | $0.25B | $1.80B | 14.07% |
| 2020-06-30 | $0.26B | $1.69B | 15.36% |
| 2020-03-31 | $0.28B | $1.58B | 17.51% |
| 2019-12-31 | $0.30B | $1.43B | 21.12% |
| 2019-09-30 | $0.29B | $1.31B | 22.23% |
| 2019-06-30 | $0.27B | $1.22B | 22.14% |
| 2019-03-31 | $0.27B | $1.13B | 23.52% |
| 2018-12-31 | $0.26B | $1.07B | 24.57% |
| 2018-09-30 | $0.25B | $1.05B | 23.98% |
| 2018-06-30 | $0.23B | $1.09B | 21.40% |
| 2018-03-31 | $0.22B | $1.14B | 19.21% |
| 2017-12-31 | $0.22B | $1.17B | 18.72% |
| 2017-09-30 | $0.21B | $1.15B | 17.85% |
| 2017-06-30 | $0.20B | $1.11B | 18.10% |
| 2017-03-31 | $0.19B | $1.06B | 17.55% |
| 2016-12-31 | $0.18B | $1.03B | 17.69% |
| 2016-09-30 | $0.17B | $1.01B | 16.98% |
| 2016-06-30 | $0.15B | $1.00B | 15.33% |
| 2016-03-31 | $0.17B | $1.00B | 16.47% |
| 2015-12-31 | $0.15B | $1.02B | 14.27% |
| 2015-09-30 | $0.12B | $1.06B | 11.37% |
| 2015-06-30 | $0.10B | $1.10B | 8.86% |
| 2015-03-31 | $0.10B | $1.15B | 8.68% |
| 2014-12-31 | $0.11B | $1.19B | 8.92% |
| 2014-09-30 | $0.12B | $1.21B | 10.09% |
| 2014-06-30 | $0.15B | $1.20B | 12.41% |
| 2014-03-31 | $0.16B | $1.16B | 13.68% |
| 2013-12-31 | $0.15B | $1.11B | 13.47% |
| 2013-09-30 | $0.13B | $1.07B | 11.91% |
| 2013-06-30 | $0.16B | $1.03B | 15.03% |
| 2013-03-31 | $0.13B | $0.99B | 13.46% |
| 2012-12-31 | $0.16B | $0.96B | 16.19% |
| 2012-09-30 | $0.17B | $0.91B | 18.74% |
| 2012-06-30 | $0.15B | $0.82B | 18.06% |
| 2012-03-31 | $0.17B | $0.77B | 21.40% |
| 2011-12-31 | $0.16B | $0.71B | 22.19% |
| 2011-09-30 | $0.16B | $0.65B | 23.85% |
| 2011-06-30 | $0.16B | $0.64B | 24.53% |
| 2011-03-31 | $0.16B | $0.59B | 26.19% |
| 2010-12-31 | $0.16B | $0.56B | 27.81% |
| 2010-09-30 | $0.18B | $0.54B | 33.26% |
| 2010-06-30 | $0.17B | $0.52B | 32.25% |
| 2010-03-31 | $0.15B | $0.51B | 29.49% |
| 2009-12-31 | $0.14B | $0.49B | 27.70% |
| 2009-09-30 | $0.11B | $0.48B | 22.65% |
| 2009-06-30 | $0.10B | $0.47B | 20.69% |
| 2009-03-31 | $0.11B | $0.48B | 22.13% |
| 2008-12-31 | $0.11B | $0.48B | 22.69% |
| 2008-09-30 | $0.13B | $0.51B | 24.37% |
| 2008-06-30 | $0.14B | $0.46B | 30.35% |
| 2008-03-31 | $0.13B | $0.40B | 33.52% |
| 2007-12-31 | $0.14B | $0.34B | 40.09% |
| 2007-09-30 | $0.16B | $0.24B | 69.27% |
| 2007-06-30 | $0.14B | $0.22B | 63.16% |
| 2007-03-31 | $0.12B | $0.22B | 54.59% |
| 2006-12-31 | $0.11B | $0.22B | 48.04% |
| 2006-09-30 | $0.03B | $0.23B | 12.46% |
| 2006-06-30 | $0.03B | $0.24B | 11.29% |
| 2006-03-31 | $0.03B | $0.24B | 10.56% |
| 2005-12-31 | $0.02B | $0.24B | 9.66% |
| 2005-09-30 | $0.02B | $0.24B | 8.06% |
| 2005-06-30 | $0.01B | $0.24B | 5.89% |
| 2005-03-31 | $0.01B | $0.24B | 3.34% |
| 2004-12-31 | $0.01B | $0.24B | 2.54% |
| 2004-09-30 | $0.00B | $0.23B | -1.72% |
| 2004-06-30 | $-0.01B | $0.23B | -4.38% |
| 2004-03-31 | $-0.01B | $0.20B | -3.93% |
| 2003-12-31 | $-0.01B | $0.18B | -5.53% |
| 2003-09-30 | $-0.01B | $0.17B | -4.02% |
| 2003-06-30 | $0.00B | $0.16B | 0.00% |
| 2003-03-31 | $0.00B | $0.16B | 1.93% |
| 2002-12-31 | $0.01B | $0.16B | 3.19% |
| 2002-09-30 | $0.00B | $0.14B | 0.71% |
| 2002-06-30 | $0.00B | $0.14B | 0.72% |
| 2002-03-31 | $0.00B | $0.14B | 1.45% |
| 2001-12-31 | $0.00B | $0.14B | 1.47% |
| 2001-09-30 | $0.00B | $0.14B | 2.21% |
| 2001-06-30 | $0.00B | $0.13B | 2.24% |
| 2001-03-31 | $0.00B | $0.11B | 1.89% |
| 2000-12-31 | $0.00B | $0.08B | 1.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |